 | • レポートコード：QYR9ST02873 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の子宮内膜がんの治療市場について調査・分析し、以下の構成でお届け致します。子宮内膜がんの治療の種類別には、化学療法、外科に、用途別には、病院、クリニックに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別子宮内膜がんの治療売上データ ・地域別子宮内膜がんの治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別子宮内膜がんの治療市場規模：化学療法、外科 ・用途別子宮内膜がんの治療市場規模：病院、クリニック ・主要メーカーの企業情報：Ariad、Abbott、BD、GlaxoSmithKline、Merck、Novartis、Sanofi、Siemens、Roche ・子宮内膜がんの治療の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The global Endometrial Cancer Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endometrial Cancer Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Endometrial Cancer Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endometrial Cancer Treatment in these regions.
This research report categorizes the global Endometrial Cancer Treatment market by top players/brands, region, type and end user. This report also studies the global Endometrial Cancer Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ariad
Abbott
BD
GlaxoSmithKline
Merck
Novartis
Sanofi
Siemens
Roche
Market size by Product
Chemotherapy
Surgical
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Endometrial Cancer Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Endometrial Cancer Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Endometrial Cancer Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Endometrial Cancer Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Endometrial Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endometrial Cancer Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Endometrial Cancer Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Endometrial Cancer Treatment Market Size Growth Rate by Product
1.4.2 Chemotherapy
1.4.3 Surgical
1.5 Market by End User
1.5.1 Global Endometrial Cancer Treatment Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Endometrial Cancer Treatment Market Size
2.1.1 Global Endometrial Cancer Treatment Revenue 2014-2025
2.1.2 Global Endometrial Cancer Treatment Sales 2014-2025
2.2 Endometrial Cancer Treatment Growth Rate by Regions
2.2.1 Global Endometrial Cancer Treatment Sales by Regions
2.2.2 Global Endometrial Cancer Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Endometrial Cancer Treatment Sales by Manufacturers
3.1.1 Endometrial Cancer Treatment Sales by Manufacturers
3.1.2 Endometrial Cancer Treatment Sales Market Share by Manufacturers
3.1.3 Global Endometrial Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Endometrial Cancer Treatment Revenue by Manufacturers
3.2.1 Endometrial Cancer Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Endometrial Cancer Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Endometrial Cancer Treatment Price by Manufacturers
3.4 Endometrial Cancer Treatment Manufacturing Base Distribution, Product Types
3.4.1 Endometrial Cancer Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Endometrial Cancer Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Endometrial Cancer Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Endometrial Cancer Treatment Sales by Product
4.2 Global Endometrial Cancer Treatment Revenue by Product
4.3 Endometrial Cancer Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Endometrial Cancer Treatment Breakdown Data by End User
6 North America
6.1 North America Endometrial Cancer Treatment by Countries
6.1.1 North America Endometrial Cancer Treatment Sales by Countries
6.1.2 North America Endometrial Cancer Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Endometrial Cancer Treatment by Product
6.3 North America Endometrial Cancer Treatment by End User
7 Europe
7.1 Europe Endometrial Cancer Treatment by Countries
7.1.1 Europe Endometrial Cancer Treatment Sales by Countries
7.1.2 Europe Endometrial Cancer Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Endometrial Cancer Treatment by Product
7.3 Europe Endometrial Cancer Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Endometrial Cancer Treatment by Countries
8.1.1 Asia Pacific Endometrial Cancer Treatment Sales by Countries
8.1.2 Asia Pacific Endometrial Cancer Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Endometrial Cancer Treatment by Product
8.3 Asia Pacific Endometrial Cancer Treatment by End User
9 Central & South America
9.1 Central & South America Endometrial Cancer Treatment by Countries
9.1.1 Central & South America Endometrial Cancer Treatment Sales by Countries
9.1.2 Central & South America Endometrial Cancer Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Endometrial Cancer Treatment by Product
9.3 Central & South America Endometrial Cancer Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Endometrial Cancer Treatment by Countries
10.1.1 Middle East and Africa Endometrial Cancer Treatment Sales by Countries
10.1.2 Middle East and Africa Endometrial Cancer Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Endometrial Cancer Treatment by Product
10.3 Middle East and Africa Endometrial Cancer Treatment by End User
11 Company Profiles
11.1 Ariad
11.1.1 Ariad Company Details
11.1.2 Company Business Overview
11.1.3 Ariad Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Ariad Endometrial Cancer Treatment Products Offered
11.1.5 Ariad Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Endometrial Cancer Treatment Products Offered
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 Company Business Overview
11.3.3 BD Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 BD Endometrial Cancer Treatment Products Offered
11.3.5 BD Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline Endometrial Cancer Treatment Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Company Business Overview
11.5.3 Merck Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck Endometrial Cancer Treatment Products Offered
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Endometrial Cancer Treatment Products Offered
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sanofi Endometrial Cancer Treatment Products Offered
11.7.5 Sanofi Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Company Business Overview
11.8.3 Siemens Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Siemens Endometrial Cancer Treatment Products Offered
11.8.5 Siemens Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Company Business Overview
11.9.3 Roche Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Roche Endometrial Cancer Treatment Products Offered
11.9.5 Roche Recent Development
12 Future Forecast
12.1 Endometrial Cancer Treatment Market Forecast by Regions
12.1.1 Global Endometrial Cancer Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Endometrial Cancer Treatment Revenue Forecast by Regions 2019-2025
12.2 Endometrial Cancer Treatment Market Forecast by Product
12.2.1 Global Endometrial Cancer Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Endometrial Cancer Treatment Revenue Forecast by Product 2019-2025
12.3 Endometrial Cancer Treatment Market Forecast by End User
12.4 North America Endometrial Cancer Treatment Forecast
12.5 Europe Endometrial Cancer Treatment Forecast
12.6 Asia Pacific Endometrial Cancer Treatment Forecast
12.7 Central & South America Endometrial Cancer Treatment Forecast
12.8 Middle East and Africa Endometrial Cancer Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Endometrial Cancer Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Endometrial Cancer Treatment Product Picture
Table Endometrial Cancer Treatment Market Segments
Table Key Manufacturers Endometrial Cancer Treatment Covered
Table Global Endometrial Cancer Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Endometrial Cancer Treatment Sales Market Share by Product 2014-2025
Figure Chemotherapy Product Picture
Table Major Manufacturers of Chemotherapy
Figure Surgical Product Picture
Table Major Manufacturers of Surgical
Table Global Endometrial Cancer Treatment Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Endometrial Cancer Treatment Report Years Considered
Figure Global Endometrial Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Endometrial Cancer Treatment Sales 2014-2025 (K Units)
Table Global Endometrial Cancer Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Endometrial Cancer Treatment Sales by Regions 2014-2019 (K Units)
Table Global Endometrial Cancer Treatment Sales Market Share by Regions 2014-2019
Figure Global Endometrial Cancer Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global Endometrial Cancer Treatment Sales Market Share by Regions
Table Global Endometrial Cancer Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Endometrial Cancer Treatment Revenue Market Share by Regions 2014-2019
Figure Global Endometrial Cancer Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global Endometrial Cancer Treatment Revenue Market Share by Regions
Table Global Endometrial Cancer Treatment Sales by Manufacturers (2014-2019) (K Units)
Table Global Endometrial Cancer Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Endometrial Cancer Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Endometrial Cancer Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Endometrial Cancer Treatment Revenue Share by Manufacturers (2014-2019)
Figure Endometrial Cancer Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers Endometrial Cancer Treatment Price (2014-2019) (USD/Unit)
Table Endometrial Cancer Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Endometrial Cancer Treatment Product Type
Table Date of International Manufacturers Enter into Endometrial Cancer Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table Global Endometrial Cancer Treatment Sales Share by Product (2014-2019)
Figure Global Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure Global Endometrial Cancer Treatment Sales Market Share by Product in 2018
Table Global Endometrial Cancer Treatment Revenue by Product (2014-2019) (Million US$)
Table Global Endometrial Cancer Treatment Revenue Share by Product (2014-2019)
Figure Global Endometrial Cancer Treatment Revenue Market Share by Product (2014-2019)
Figure Global Endometrial Cancer Treatment Revenue Market Share by Product in 2018
Table Endometrial Cancer Treatment Price by Product 2014-2019 (USD/Unit)
Table Global Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table Global Endometrial Cancer Treatment Sales Share by End User (2014-2019)
Figure Global Sales Endometrial Cancer Treatment Market Share by End User (2014-2019)
Figure Global Sales Endometrial Cancer Treatment Market Share by End User in 2018
Figure North America Endometrial Cancer Treatment Sales Growth Rate 2014-2019 (K Units)
Figure North America Endometrial Cancer Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America Endometrial Cancer Treatment Sales by Countries (2014-2019) (K Units)
Table North America Endometrial Cancer Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America Endometrial Cancer Treatment Sales Market Share by Countries
Table North America Endometrial Cancer Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America Endometrial Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Endometrial Cancer Treatment Revenue Market Share by Countries
Figure United States Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure United States Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Canada Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table North America Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America Endometrial Cancer Treatment Market Share by Product
Table North America Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table North America Endometrial Cancer Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America Endometrial Cancer Treatment Market Share by End User
Figure Europe Endometrial Cancer Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Europe Endometrial Cancer Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Endometrial Cancer Treatment Sales by Countries (2014-2019) (K Units)
Table Europe Endometrial Cancer Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Endometrial Cancer Treatment Sales Market Share by Countries
Table Europe Endometrial Cancer Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe Endometrial Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Endometrial Cancer Treatment Revenue Market Share by Countries
Figure Germany Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Germany Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure France Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure UK Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Italy Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Russia Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table Europe Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe Endometrial Cancer Treatment Market Share by Product
Table Europe Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table Europe Endometrial Cancer Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe Endometrial Cancer Treatment Market Share by End User
Figure Asia Pacific Endometrial Cancer Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Endometrial Cancer Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Endometrial Cancer Treatment Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Endometrial Cancer Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Endometrial Cancer Treatment Sales Market Share by Countries
Table Asia Pacific Endometrial Cancer Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Endometrial Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Endometrial Cancer Treatment Revenue Market Share by Countries
Figure China Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure China Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Japan Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Korea Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure India Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Australia Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table Asia Pacific Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Endometrial Cancer Treatment Market Share by Product
Table Asia Pacific Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table Asia Pacific Endometrial Cancer Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Endometrial Cancer Treatment Market Share by End User
Figure Central & South America Endometrial Cancer Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Endometrial Cancer Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Endometrial Cancer Treatment Sales by Countries (2014-2019) (K Units)
Table Central & South America Endometrial Cancer Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Endometrial Cancer Treatment Sales Market Share by Countries
Table Central & South America Endometrial Cancer Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Endometrial Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Endometrial Cancer Treatment Revenue Market Share by Countries
Figure Brazil Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table Central & South America Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Endometrial Cancer Treatment Market Share by Product
Table Central & South America Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table Central & South America Endometrial Cancer Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Endometrial Cancer Treatment Market Share by End User
Figure Middle East and Africa Endometrial Cancer Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Endometrial Cancer Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Endometrial Cancer Treatment Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Endometrial Cancer Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Endometrial Cancer Treatment Sales Market Share by Countries
Table Middle East and Africa Endometrial Cancer Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Endometrial Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Endometrial Cancer Treatment Revenue Market Share by Countries
Figure GCC Countries Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Endometrial Cancer Treatment Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Endometrial Cancer Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Endometrial Cancer Treatment Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Endometrial Cancer Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Endometrial Cancer Treatment Market Share by Product
Table Middle East and Africa Endometrial Cancer Treatment Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Endometrial Cancer Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Endometrial Cancer Treatment Market Share by End User
Table Ariad Company Details
Table Ariad Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ariad Recent Development
Table Abbott Company Details
Table Abbott Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table BD Company Details
Table BD Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BD Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Siemens Company Details
Table Siemens Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Siemens Recent Development
Table Roche Company Details
Table Roche Endometrial Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Global Endometrial Cancer Treatment Sales Forecast by Regions 2019-2025 (K Units)
Table Global Endometrial Cancer Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Endometrial Cancer Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Endometrial Cancer Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global Endometrial Cancer Treatment Sales Forecast by Product 2019-2025 (K Units)
Table Global Endometrial Cancer Treatment Sales Market Share Forecast by Product 2019-2025
Table Global Endometrial Cancer Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Endometrial Cancer Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global Endometrial Cancer Treatment Sales Forecast by End User 2019-2025 (K Units)
Table Global Endometrial Cancer Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America Endometrial Cancer Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Endometrial Cancer Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Endometrial Cancer Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Endometrial Cancer Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Endometrial Cancer Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Endometrial Cancer Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Endometrial Cancer Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Endometrial Cancer Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Endometrial Cancer Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Endometrial Cancer Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Endometrial Cancer Treatment Value Chain
Table Endometrial Cancer Treatment Customers List
Table Endometrial Cancer Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
子宮内膜癌の世界市場：市場規模・現状・予測 Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual per…- 膵臓癌治療の世界市場：インサイト・予測 Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body.The global Pancreatic Cancer Treatment market is valued at xx million US$ in 2018 and …
- 子宮内膜アブレーションの世界市場：市場規模・現状・予測 Endometrial ablation is a non-invasive procedure which results in destruction of or ablation of the outermost lining of uterus called endometrium.The endometrial ablation is essentially used in the treatment of abnormal uterine bleeding. In addition, prolonged abnormal uterine bleeding can result in…
- 前立腺癌治療の世界市場：市場規模・現状・予測 Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.In 2018, the global Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAG…
- 癌温熱療法の世界市場：インサイト・予測 The global Hyperthermia Treatment for Cancer market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hyperthermia Treatment for Cancer market based o…